Literature DB >> 24258997

Detection of chondroitin sulfate proteoglycan 4 (CSPG4) in melanoma.

Yangyang Wang1, Francesco Sabbatino, Xinhui Wang, Soldano Ferrone.   

Abstract

The tumor antigen chondroitin sulfate proteoglycan 4 (CSPG4) appears to be a useful biomarker to identify melanoma cells and an attractive target to apply antibody-based immunotherapy for the treatment of melanoma. Here we described the reverse transcription-polymerase chain reaction (RT-PCR) method and the immunohistochemical (IHC) staining method to detect the expression of CSPG4 in melanoma cells and tissues.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24258997     DOI： 10.1007/978-1-62703-727-3_28

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  10 in total

Review 1.  The potential of tumor-derived exosomes for noninvasive cancer monitoring: an update.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2018-11-09       Impact factor: 5.225

2.  Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain.

Authors:  Jianbo Yang; Matthew A Price; Leah E C Wanshura; Jinsong He; Mei Yi; Danny R Welch; Guiyuan Li; Sean Conner; Jonathan Sachs; Eva A Turley; James B McCarthy
Journal:  Melanoma Res       Date:  2019-08       Impact factor: 3.599

Review 3.  The Role of Extracellular Vesicles in Melanoma Progression.

Authors:  Evelyn Lattmann; Mitchell P Levesque
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

Review 4.  The potential of tumor-derived exosomes for noninvasive cancer monitoring.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2015-08-02       Impact factor: 5.225

5.  CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.

Authors:  Valeria Leuci; Chiara Donini; Giovanni Grignani; Ramona Rotolo; Giulia Mesiano; Erika Fiorino; Loretta Gammaitoni; Lorenzo D'Ambrosio; Alessandra Merlini; Elisa Landoni; Enzo Medico; Sonia Capellero; Lidia Giraudo; Giulia Cattaneo; Ilenia Iaia; Ymera Pignochino; Marco Basiricò; Elisa Vigna; Alberto Pisacane; Franca Fagioli; Soldano Ferrone; Massimo Aglietta; Gianpietro Dotti; Dario Sangiolo
Journal:  Clin Cancer Res       Date:  2020-09-08       Impact factor: 12.531

6.  Immunoaffinity-Based Isolation of Melanoma Cell-Derived and T Cell-Derived Exosomes from Plasma of Melanoma Patients.

Authors:  Sujan Kumar Mondal; Theresa L Whiteside
Journal:  Methods Mol Biol       Date:  2021

7.  Evaluation of Exosome Proteins by on-Bead Flow Cytometry.

Authors:  Marie-Nicole Theodoraki; Chang-Sook Hong; Vera S Donnenberg; Albert D Donnenberg; Theresa L Whiteside
Journal:  Cytometry A       Date:  2020-08-21       Impact factor: 4.714

8.  Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma.

Authors:  Priyanka Sharma; Sonja Ludwig; Laurent Muller; Chang Sook Hong; John M Kirkwood; Soldano Ferrone; Theresa L Whiteside
Journal:  J Extracell Vesicles       Date:  2018-02-15

9.  Chondroitin sulfate proteoglycan-4 (CSPG4)-specific monoclonal antibody 225.28 in detection of acute myeloid leukemia blasts.

Authors:  Moon Fenton; Theresa L Whiteside; Soldano Ferrone; Michael Boyiadzis
Journal:  Oncol Res       Date:  2015       Impact factor: 5.574

Review 10.  Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology.

Authors:  Theresa L Whiteside; Brenda Diergaarde; Chang-Sook Hong
Journal:  Int J Mol Sci       Date:  2021-06-09       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.